Neoadjuvant Toripalimab plus Nimotuzumab combined with Taxol-based Chemotherapy (TNT) in Locally Advanced Penile Squamous Cell Carcinoma
Biomarker analysis showed that PD-L1 expression, TP53 mutation status, and CD8+ T cell density may serve as predictive biomarkers